The immune system does not behave in the same way in every tissue. Discover how the first UniSR – @tsinghuauniversity.bsky.social symposium is advancing research into cancer immunotherapy, neuroimmune interactions and immune memory. 👉Read more: blog.unisr.it/en/immunolog... @iannaconelab.bsky.social

Immunology Research: Findings from UniSR-Tsinghua

Immunology research from the UniSR-Tsinghua symposium reveals new cancer immunotherapy targets and deepens the brain-immune system dialogue.

blog.unisr.it

🔬 Recruiting a Physician Scientist PhD student (San Raffaele, Milan) via AIRC-Cariplo-SEMM-UniMi program. Project: reprogramming tumor endothelium to restore anti-tumor immunity in liver cancer. Keep 20% clinical work. Deadline Sept 16. Apply: tinyurl.com/3vcp27dp #AIRC

Great science and fun at our lab's annual retreat, bringing together my team with @mirelakuka.bsky.social, Marco De Giovanni, and Donato Inverso's teams. Thanks to @lozanzi.bsky.social and Stefano Sammicheli for inspiring lectures and great questions. Proud of what we've built together.

In vista della Giornata Mondiale dell'Epatite (28 luglio), abbiamo raccontato a UniSR le due strategie complementari su cui lavoriamo per la cura funzionale dell'epatite B cronica 🔗 blog.unisr.it/cura-funzion...

Cura funzionale epatite B cronica: le nuove strategie

Antivirali di nuova generazione e immunoterapia: le strategie con cui UniSR e IRCCS San Raffaele affrontano la cura funzionale dell'epatite B cronica.

blog.unisr.it

Huge congrats to Dr. Valentina Venzin, former PhD student in my lab, for being awarded the EFIS ACTERIA Doctoral Thesis Prize in Immunology! Her discovery of a liver-intrinsic CD4-to-CD8 T cell rescue circuit via IL-27 was a really elegant piece of work. So proud of her! www.efis.org/news/the-fon...

Exciting news😀LiveRNA, co-founded by @iannaconelab.bsky.social, has been selected for the BOOST Grant from the Paris-Saclay Cancer Cluster. The award will accelerate the development of a next-generation #mRNA #immunotherapy platform, advancing innovative cancer treatments toward the clinic.

The countdown is on - Just 31 days until #CancerImmuno 2026! ⏳AND there's still time to join us! If you're interested in attending, please contact felicity@fusion-conferences.com for more information. 🔗Conference Website: bit.ly/4vAsVgd #FusionImmunology #FusionCancerResearch

Pleased to have contributed to this new @science.org paper on how lymphoid tissue chemokines limit CD8⁺ T cell priming duration to preserve T cell functionality. Congrats to Lukas Altenburger and Jens Stein! t.co/K9Cmt8yO9C

📣 Join us on a journey through Treg time! Celebrating the 2026 Day of Immunology with a featured EJI collection on Tregs — highlighting landmark work on immune tolerance, including foundational contributions from Shimon Sakaguchi and colleagues. A must-read for ECRs and beyond! bit.ly/4mXCa75

📢Travel Grant Opportunity for #ECRs 🙌Proud to announce that #EFIS, together with the @eurjimmunol.bsky.social, is offering 5 travel grants (€1,000 each) to support attendance at the GRC! 💡Grants will be awarded based on scientific merit, career stage + inclusion criteria. ⏰Deadline: 1 May 2026

With @hiroshi-ichise.bsky.social, closing the @ccii-kyoto.bsky.social workshop on advanced imaging and image analysis in Kyoto. Thanks to Guolan Lu (Stanford), @iannaconelab.bsky.social, Andrea Radtke (Leica), Yuki Sugiura (CCII), and Johanne T. Jacobsen for great lectures and practicals!

Matteo Iannacone @iannaconelab.bsky.social gave a tour de force presentation on liver immunity, hosted by @hiroshi-ichise.bsky.social as part of the CCII workshop on Advanced Tissue Imaging & Image Analysis #Immunology #TissueImmunity www.ccii.med.kyoto-u.ac.jp/en/event/eve...

Review @natrevimmunol.nature.com @gustaveroussy.fr @iannaconelab.bsky.social Kupffer cells in liver homeostasis and disease: from immune sentinels to metabolic gatekeepers www.nature.com/articles/s41...

Great fun to write this review on Kupffer cells with Florent Ginhoux and Paul Kubes, covering origin, diversity and roles in immunity and metabolism, now out in @natrevimmunol.nature.com. Huge credit to Bruna Araujo David, Francesco Andreata and Camille Blériot for driving this work. t.co/rGpmTMRddV

Neutralizing antibodies are not the whole story. In our Comment in Nature Reviews Immunology, we highlight an alternative mode of protection: 👉 T cells can eliminate infection at its earliest stage — before it becomes detectable We term this “abortive infection” 🔗 rdcu.be/fbq8p Thread 1/4

Abortive infection: T cells as early, antibody-independent defenders

Nature Reviews Immunology - Neutralizing antibodies are widely viewed as the frontline of antiviral defence. Yet emerging evidence reveals that T cells can terminate infection before it is...

rdcu.be

Excited to organize @keystoneSymposia.bsky.social Tissue and Spatial Immunology with @leilaakkari.bsky.social and Hai Qi in February 2027! Join us to explore emerging research in Banff! keysym.us/KSSpatialImmune27 #KSSpatialImmune27

Tissue and Spatial Immunology | Keystone Symposia

Join us at the Keystone Symposia on Tissue and Spatial Immunology, February 2027, in Banff, with field leaders!

keysym.us

Join us for the 2026 GRC Immunochemistry and Immunobiology "Immune Circuitry and Molecular Pathways in Tissue Homeostasis, Infection, and Disease" in beautiful Barcelona. June 28 - July 3, 2026. Great lineup of speakers! www.grc.org/immunochemis...

Don't miss the 2026 Global Immunotalks!

📢Want to speak at the #CancerImmuno conference? Good news! The chairs have released additional short talk slots and extended the submission deadline to 26 February 2026! Submit your abstract for a chance to present your work alongside leading researchers in the field. 👉 Register now: bit.ly/3NRB7Iu

📩 Submit the paper link + short statement (≤250 words) to ejied@wiley.com by 15 April 2026. The winner will be selected by EJI editors together with @yefis-immunology.bsky.social representatives. #Immunology #ImmunoSky #AcademicSky #EarlyCareerResearchers #ECR @efis-immunology.bsky.social

🏆Nominations are OPEN for the 2026 EJI-EFIS Prize for the ECR Article of the Year! Best paper published in EJI (2025) by an early-career researcher wins €5,000 + travel grant to ECI 2027 (Florence)✈️ 🔗 Details & eligibility: bit.ly/41GeiMi 🫵 Self-nominations encouraged!

European Journal of Immunology: EJI-EFIS Prize for the ECR Article of the Year

EJI and EFIS are thrilled to announce a new prize honoring Early Career Researchers (ECRs) whose work is published in EJI. This initiative aims to showcase the next generation of immunologists and encourage them to submit their excellent research to EJI.

onlinelibrary.wiley.com

Great story from the Nieswandt lab in Science: uncovering a non-classical platelet mechanism that drives inflammation via integrin- and tetraspanin-rich tethers. A fresh angle on thrombo-inflammation. Happy to be part of this work! www.science.org/doi/10.1126/...

Platelet-derived integrin- and tetraspanin-enriched tethers exacerbate severe inflammation

Platelet integrin αIIbβ3 is essential for hemostasis, thrombosis, and inflammation. We found that ligation of αIIbβ3 by von Willebrand factor or fibrin under flow triggered its accumulation in plasma ...

science.org

1/ New from our lab 🧪 ARTC2 blockade is widely used to protect tissue Tregs — but when is it truly essential, and for which subsets? 2/ In this @eurjimmunol.bsky.social update, we dissect the subset-specific and context-dependent effects of ARTC2 blockade on hepatic Treg recovery.

Optimising Recovery of Hepatic Regulatory T Cells: A Practical Guide Using ARTC2 Blockade

This is an update to the Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition), Chapter 3: 12C, by Cossarizza et al. Administration of anti-ARTC2 nanobody...

onlinelibrary.wiley.com

Thrilled to contribute to this landmark consensus effort led by Dave Masopust and Rafi Ahmed. A major step toward clearer, shared T cell nomenclature for the field. www.nature.com/articles/s41...

Guidelines for T cell nomenclature - Nature Reviews Immunology

This Consensus Statement clarifies the existing subset-based nomenclature for T cells. Furthermore, it proposes an alternative modular nomenclature that is designed to be brief and flexible and to avo...

nature.com

Honoured to see our @natimmunol.nature.com study highlighted in a thoughtful @jhepatology.bsky.social commentary on the IL-27/Kupffer cell axis in chronic HBV — a great summary of why tissue immunity matters and of our work. Paper: tinyurl.com/yt652mxa Commentary: tinyurl.com/56pke5x5

CD4+ T cells license Kupffer cells to reverse CD8+ T cell dysfunction induced by hepatocellular priming - Nature Immunology

Here the authors show that CD4+ effector T cells prevent or reverse CD8+ T cell dysfunction by licensing Kupffer cells to trigger IL-27 production, defining a liver-specific immune circuit and a poten...

nature.com

New review out! 😊 20 years after it’s discovery, with @iannaconelab.bsky.social we decided to bring together what we currently know about this cytokine and how it shapes CD8 T cell responses. A small contribution to make sense of a field that is moving fast 🌈 @cp-trendsimmuno.bsky.social

Trends in Immunology@cp-trendsimmuno.bsky.social · 9mo ago

Reframing IL-27: a central regulator of CD8+ T cell immunity #immunology

New review out in @cp-trendsimmuno.bsky.social! With @valentinavenzin.bsky.social, we revisit IL-27 as a central regulator of CD8⁺ T cell fate — integrating insights from infection, cancer, and autoimmunity, and outlining its therapeutic potential. www.sciencedirect.com/science/arti...

Reframing IL-27: a central regulator of CD8+ T cell immunity

Interleukin-27 (IL-27), a member of the IL-12 cytokine family, was long viewed primarily as a regulator of CD4+ T cell immunity. Subsequent studies re…

sciencedirect.com

#CancerImmuno speaker list is live!📢 Join us in sunny Lisbon, July 2026. Register now and submit your talk to share your research. Early Bird Deadline: 15 Jan 2026 👉 Click here to register: bit.ly/4qZVqmd #FusionImmunology #FusionCancerResearch

🎤 Our next episode it out! We chat with Professor Matteo Iannacone ( @iannaconelab.bsky.social ) from @@unisr.bsky.socialabout his work understanding the generation of dysfunctional adaptive immune cells in chronic #HepatitisBVirus infection. 🎧 Listen now: https://bit.ly/4o2W8xa

Join us for this exciting meeting! @embo.org Workshop "Pathogen Immunity and Signalling", 8-12 June, 2026, Leiden, The Netherlands meetings.embo.org/event/26-pat...